The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by Influenza Vaccines Revenue 1.5 Market Analysis by Type 1.5.1 Global Influenza Vaccines Market Size Growth Rate by Type: 2020 VS 2026 1.5.2 Trivalent Flu Vaccines 1.5.3 Quadrivalent Flu Vaccines 1.6 Market by Application 1.6.1 Global Influenza Vaccines Market Share by Application: 2021-2026 1.6.2 Adults 1.6.3 Pediatrics 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global Influenza Vaccines Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter's Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global Influenza Vaccines Market Players Profiles 3.1 AstraZeneca 3.1.1 AstraZeneca Company Profile 3.1.2 AstraZeneca Influenza Vaccines Product Specification 3.1.3 AstraZeneca Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.2 FOLIA BIOTECH 3.2.1 FOLIA BIOTECH Company Profile 3.2.2 FOLIA BIOTECH Influenza Vaccines Product Specification 3.2.3 FOLIA BIOTECH Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.3 Sanofi 3.3.1 Sanofi Company Profile 3.3.2 Sanofi Influenza Vaccines Product Specification 3.3.3 Sanofi Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.4 CSL 3.4.1 CSL Company Profile 3.4.2 CSL Influenza Vaccines Product Specification 3.4.3 CSL Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.5 FluGen 3.5.1 FluGen Company Profile 3.5.2 FluGen Influenza Vaccines Product Specification 3.5.3 FluGen Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.6 GlaxoSmithKline 3.6.1 GlaxoSmithKline Company Profile 3.6.2 GlaxoSmithKline Influenza Vaccines Product Specification 3.6.3 GlaxoSmithKline Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.7 Green Cross 3.7.1 Green Cross Company Profile 3.7.2 Green Cross Influenza Vaccines Product Specification 3.7.3 Green Cross Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.8 BionVax 3.8.1 BionVax Company Profile 3.8.2 BionVax Influenza Vaccines Product Specification 3.8.3 BionVax Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.9 Altimmune 3.9.1 Altimmune Company Profile 3.9.2 Altimmune Influenza Vaccines Product Specification 3.9.3 Altimmune Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.10 Genentech 3.10.1 Genentech Company Profile 3.10.2 Genentech Influenza Vaccines Product Specification 3.10.3 Genentech Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.11 SK Chemicals 3.11.1 SK Chemicals Company Profile 3.11.2 SK Chemicals Influenza Vaccines Product Specification 3.11.3 SK Chemicals Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.12 Vaxart 3.12.1 Vaxart Company Profile 3.12.2 Vaxart Influenza Vaccines Product Specification 3.12.3 Vaxart Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.13 Medicago 3.13.1 Medicago Company Profile 3.13.2 Medicago Influenza Vaccines Product Specification 3.13.3 Medicago Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.14 Visterra 3.14.1 Visterra Company Profile 3.14.2 Visterra Influenza Vaccines Product Specification 3.14.3 Visterra Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.15 UNM Pharma 3.15.1 UNM Pharma Company Profile 3.15.2 UNM Pharma Influenza Vaccines Product Specification 3.15.3 UNM Pharma Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.16 Shijiazhuang Yiling Pharmaceutical 3.16.1 Shijiazhuang Yiling Pharmaceutical Company Profile 3.16.2 Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Product Specification 3.16.3 Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.17 Moderna Therapeutics 3.17.1 Moderna Therapeutics Company Profile 3.17.2 Moderna Therapeutics Influenza Vaccines Product Specification 3.17.3 Moderna Therapeutics Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.18 Vaxine Pty 3.18.1 Vaxine Pty Company Profile 3.18.2 Vaxine Pty Influenza Vaccines Product Specification 3.18.3 Vaxine Pty Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.19 Vaccitech 3.19.1 Vaccitech Company Profile 3.19.2 Vaccitech Influenza Vaccines Product Specification 3.19.3 Vaccitech Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.20 Novavax 3.20.1 Novavax Company Profile 3.20.2 Novavax Influenza Vaccines Product Specification 3.20.3 Novavax Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2015-2020) 4 Global Influenza Vaccines Market Competition by Market Players 4.1 Global Influenza Vaccines Production Capacity Market Share by Market Players (2015-2020) 4.2 Global Influenza Vaccines Revenue Market Share by Market Players (2015-2020) 4.3 Global Influenza Vaccines Average Price by Market Players (2015-2020) 5 Global Influenza Vaccines Production by Regions (2015-2020) 5.1 North America 5.1.1 North America Influenza Vaccines Market Size (2015-2020) 5.1.2 Influenza Vaccines Key Players in North America (2015-2020) 5.1.3 North America Influenza Vaccines Market Size by Type (2015-2020) 5.1.4 North America Influenza Vaccines Market Size by Application (2015-2020) 5.2 East Asia 5.2.1 East Asia Influenza Vaccines Market Size (2015-2020) 5.2.2 Influenza Vaccines Key Players in East Asia (2015-2020) 5.2.3 East Asia Influenza Vaccines Market Size by Type (2015-2020) 5.2.4 East Asia Influenza Vaccines Market Size by Application (2015-2020) 5.3 Europe 5.3.1 Europe Influenza Vaccines Market Size (2015-2020) 5.3.2 Influenza Vaccines Key Players in Europe (2015-2020) 5.3.3 Europe Influenza Vaccines Market Size by Type (2015-2020) 5.3.4 Europe Influenza Vaccines Market Size by Application (2015-2020) 5.4 South Asia 5.4.1 South Asia Influenza Vaccines Market Size (2015-2020) 5.4.2 Influenza Vaccines Key Players in South Asia (2015-2020) 5.4.3 South Asia Influenza Vaccines Market Size by Type (2015-2020) 5.4.4 South Asia Influenza Vaccines Market Size by Application (2015-2020) 5.5 Southeast Asia 5.5.1 Southeast Asia Influenza Vaccines Market Size (2015-2020) 5.5.2 Influenza Vaccines Key Players in Southeast Asia (2015-2020) 5.5.3 Southeast Asia Influenza Vaccines Market Size by Type (2015-2020) 5.5.4 Southeast Asia Influenza Vaccines Market Size by Application (2015-2020) 5.6 Middle East 5.6.1 Middle East Influenza Vaccines Market Size (2015-2020) 5.6.2 Influenza Vaccines Key Players in Middle East (2015-2020) 5.6.3 Middle East Influenza Vaccines Market Size by Type (2015-2020) 5.6.4 Middle East Influenza Vaccines Market Size by Application (2015-2020) 5.7 Africa 5.7.1 Africa Influenza Vaccines Market Size (2015-2020) 5.7.2 Influenza Vaccines Key Players in Africa (2015-2020) 5.7.3 Africa Influenza Vaccines Market Size by Type (2015-2020) 5.7.4 Africa Influenza Vaccines Market Size by Application (2015-2020) 5.8 Oceania 5.8.1 Oceania Influenza Vaccines Market Size (2015-2020) 5.8.2 Influenza Vaccines Key Players in Oceania (2015-2020) 5.8.3 Oceania Influenza Vaccines Market Size by Type (2015-2020) 5.8.4 Oceania Influenza Vaccines Market Size by Application (2015-2020) 5.9 South America 5.9.1 South America Influenza Vaccines Market Size (2015-2020) 5.9.2 Influenza Vaccines Key Players in South America (2015-2020) 5.9.3 South America Influenza Vaccines Market Size by Type (2015-2020) 5.9.4 South America Influenza Vaccines Market Size by Application (2015-2020) 5.10 Rest of the World 5.10.1 Rest of the World Influenza Vaccines Market Size (2015-2020) 5.10.2 Influenza Vaccines Key Players in Rest of the World (2015-2020) 5.10.3 Rest of the World Influenza Vaccines Market Size by Type (2015-2020) 5.10.4 Rest of the World Influenza Vaccines Market Size by Application (2015-2020) 6 Global Influenza Vaccines Consumption by Region (2015-2020) 6.1 North America 6.1.1 North America Influenza Vaccines Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia Influenza Vaccines Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe Influenza Vaccines Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia Influenza Vaccines Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia Influenza Vaccines Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East Influenza Vaccines Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa Influenza Vaccines Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania Influenza Vaccines Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America Influenza Vaccines Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World Influenza Vaccines Consumption by Countries 7 Global Influenza Vaccines Production Forecast by Regions (2021-2026) 7.1 Global Forecasted Production of Influenza Vaccines (2021-2026) 7.2 Global Forecasted Revenue of Influenza Vaccines (2021-2026) 7.3 Global Forecasted Price of Influenza Vaccines (2021-2026) 7.4 Global Forecasted Production of Influenza Vaccines by Region (2021-2026) 7.4.1 North America Influenza Vaccines Production, Revenue Forecast (2021-2026) 7.4.2 East Asia Influenza Vaccines Production, Revenue Forecast (2021-2026) 7.4.3 Europe Influenza Vaccines Production, Revenue Forecast (2021-2026) 7.4.4 South Asia Influenza Vaccines Production, Revenue Forecast (2021-2026) 7.4.5 Southeast Asia Influenza Vaccines Production, Revenue Forecast (2021-2026) 7.4.6 Middle East Influenza Vaccines Production, Revenue Forecast (2021-2026) 7.4.7 Africa Influenza Vaccines Production, Revenue Forecast (2021-2026) 7.4.8 Oceania Influenza Vaccines Production, Revenue Forecast (2021-2026) 7.4.9 South America Influenza Vaccines Production, Revenue Forecast (2021-2026) 7.4.10 Rest of the World Influenza Vaccines Production, Revenue Forecast (2021-2026) 7.5 Forecast by Type and by Application (2021-2026) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026) 7.5.2 Global Forecasted Consumption of Influenza Vaccines by Application (2021-2026) 8 Global Influenza Vaccines Consumption Forecast by Regions (2021-2026) 8.1 North America Forecasted Consumption of Influenza Vaccines by Country 8.2 East Asia Market Forecasted Consumption of Influenza Vaccines by Country 8.3 Europe Market Forecasted Consumption of Influenza Vaccines by Countriy 8.4 South Asia Forecasted Consumption of Influenza Vaccines by Country 8.5 Southeast Asia Forecasted Consumption of Influenza Vaccines by Country 8.6 Middle East Forecasted Consumption of Influenza Vaccines by Country 8.7 Africa Forecasted Consumption of Influenza Vaccines by Country 8.8 Oceania Forecasted Consumption of Influenza Vaccines by Country 8.9 South America Forecasted Consumption of Influenza Vaccines by Country 8.10 Rest of the world Forecasted Consumption of Influenza Vaccines by Country 9 Global Influenza Vaccines Sales by Type (2015-2026) 9.1 Global Influenza Vaccines Historic Market Size by Type (2015-2020) 9.2 Global Influenza Vaccines Forecasted Market Size by Type (2021-2026) 10 Global Influenza Vaccines Consumption by Application (2015-2026) 10.1 Global Influenza Vaccines Historic Market Size by Application (2015-2020) 10.2 Global Influenza Vaccines Forecasted Market Size by Application (2021-2026) 11 Global Influenza Vaccines Manufacturing Cost Analysis 11.1 Influenza Vaccines Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of Influenza Vaccines 12 Global Influenza Vaccines Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 Influenza Vaccines Distributors List 12.3 Influenza Vaccines Customers 12.4 Influenza Vaccines Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer
Price : US$ 3,500 | Date : Mar 2024 |
Category : Manufacturing and Construction | Pages : 110 |
Price : US$ 2,600 | Date : Nov 2023 |
Category : Healthcare and Pharmaceuticals | Pages : 141 |
Price : US$ 2,600 | Date : Nov 2023 |
Category : Healthcare and Pharmaceuticals | Pages : 142 |
Price : US$ 2,600 | Date : Nov 2023 |
Category : Healthcare and Pharmaceuticals | Pages : 132 |
Price : US$ 3,200 | Date : Nov 2023 |
Category : Healthcare and Pharmaceuticals | Pages : 211 |
We will be happy to help you find what you need. Please call us or write to us: